NOOTAN MEDICAL COLLEGE AND RESEARCH CENTRE & NOOTAN GENERAL HOSPITAL

  • Virtual Tour

Nootan Medical College and Research Centre & Nootan General Hospital

Sankalchand Patel University

Respiratory Medicine

Menu

Respiratory Medicine

Head of the Department Details:

…..

Dr. Rajesh Solanki

Designation: Professor & Head
Degree: MBBS, MD (Respiratory Medicine)
Official Email Id : rns04sec@yahoo.co.in, drsolanki20012yahoo.co.in

The Respiratory Medicine  Department specializes in diagnosing, treating, and managing tuberculosis (TB) and other respiratory diseases. Here are some peculiarities of this department:

  1. *Infectious disease management*: TB is a highly infectious disease, and the department must follow strict infection control protocols to prevent the spread of the disease to patients, staff, and visitors.
  2. *Complex diagnosis*: Diagnosing TB and other respiratory diseases can be complex and requires a combination of clinical evaluation, imaging studies, and laboratory tests.
  3. *Multidrug-resistant TB*: The department may encounter cases of multidrug-resistant TB, which requires specialized treatment and management.
  4. *Chronic disease management*: Many respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, require long-term management and follow-up.
  5. *Pulmonary rehabilitation*: The department may offer pulmonary rehabilitation programs to help patients with chronic respiratory diseases manage their symptoms and improve their quality of life.
  6. *Collaboration with other departments*: The TB and Respiratory Disease Department often collaborates with other departments, such as radiology, pathology, and pharmacy, to provide comprehensive care to patients.
  7. *Public health implications*: TB is a public health concern, and the department may be involved in contact tracing, outbreak investigation, and other public health activities.
  8. *Research and development*: The department may be involved in research studies and clinical trials to develop new treatments and diagnostic tools for TB and other respiratory diseases.
  9. *Patient education and counseling*: The department provides patient education and counseling on disease management, treatment adherence, and lifestyle modifications.
  10. *Emotional support*: Patients with TB and other respiratory diseases may experience emotional distress, and the department provides emotional support and counseling to help patients cope with their condition.

Respiratory Medicine Department provides services as mentioned below:

  1. Fiber Optic Bronchoscopy
  2. Pleural tapping (Thoracocentesis)
  • Intercostal Drainage tube insertion
  1. Chest Physiotherapy / Pulmonary Rehabilitation
  2. Pulmonary Function Test (Spirometry)
  3. Intensive Respiratory Care Unit with Arterial Blood Gas Analysis & Mechanical Ventilation support
  • Aerosol Therapy (Nebulization)
  • Microscopy Center and DOT Center for TB services
  1. Facilities for Diagnosis and Management of MDR TB
  2. USG/CT Guided Lung Biopsy
  3. ALLERGY TESTING

Respiratory Medicine

Name: Dr. Rajesh Natvarlal Solanki
Education Qualification: MD (Respiratory Medicine)
Designation: Professor
Registration Number (UG): G-12915
Registration Number (PG): G-2970

Name: Dr. Bhogilal Vitthaldas Patel
Education Qualification: MD (Respiratory Medicine)
Designation: Associate Professor
Registration Number (UG): G-12572
Registration Number (PG): G-3264

Name: Dr. Jaysinh Rathva
Education Qualification: MBBS, MD
Designation: Assistant Professor
Registration Number (UG): G-50574
Registration Number (PG): G-32051

Publications:

Dr Rajesh Solanki

  1. Efficacy of Sparfloxacin as an add on Drug in the treatment of MDR-TB, page  28-32, JAMA India-The Physicians’ Update, vol.2, no.7,  July 1999
  2. Publication of “SOURCE OF LATEST ANTI-TB TREATMENT AMONGST RE-TREATMENT TB CASES  REGISTERED UNDER RNTCP IN GUJARAT, National Journal of Community Medicine, Volume 2, issue 2,  Page no. 181-185, Jan-sept. 2011, (pISSN 0976-3325, e ISSN 2229-6816 )
  3. “Proficiency Panel Testing – A Reliable Tool in External Quality Assessment of Sputum Smear Microscopy services in Gujarat, India”, Indian Journal of Tuberculosis, Page no. 113-119, issue 58, 2011
  4. Study of “Impact of the RNTCP IRL-OSE Visits on Quality of sputum smear microscopy services of Gujarat, India”, Indian Journal of Tuberculosis, 59, 12-17, 2012
  5. “Multi centric Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis (INSEARCH)” by Indian Council of Medical Research in 2006-2009, INT J TUBERC LUNG DIS16(9)1270-1277@2012 The Union http://dx.DOI.org/10.5588/ijtld.12.0005
  6. Editorial Article on “ Drug Resistant Tuberculosis: New Challenges” in Indian Journal of Chest Diseases and Allied Sciences Page no. 159-160, Volume-54, No. 3, ISSN 0377 9343,  July-September 2012
  7. Publication of “Outcomes of Cat III DOT Treatment in Immuno competent patients with Tuberculous Pleural Effusion.” International Journal of TB & Lung Diseases,  16(11) 1505-1509, 2012 (http//dx.dol.org/10.5588/ijtld.12.0233)
  8. “Socio demographic Profile and Clinical Presentation of Collagen Vascular Diseases with Pulmonary Symptoms: A descriptive study Cross Sectional, National Journal of Medical Research,Volume 3, issue 1,page no. 27-29, ISSN2249 4995, eISSN 2277 8810 March 2013
  9. Publication of “A Multi-Site Validation in India of the Line Probe Assay for the Rapid

Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens”, PLOS One, Volume 9, issue 2, Page no. 1-8, February 2014, (e88626)

 

  1. Publication of “Retrospective Analytical study of prospectively collected data of 

Patients of Lung Carcinoma confirmed by Histologically carried out at B J Medical College, Ahmedabad, Gujarat” Page no. 84-87, 3 (2), International Journal of respiratory

Medicine, 2014 (pISSN 2320-2734, eISSN 2320-2742)

  1. Publication on “Treatment outcome of Standardized Regimen in patients with

Multi Drug Resistant Tuberculosis” Journal of Pharmacology and Pharmacotherapeutics, Page no. 145-149, Volume -5, issue 2 April-June, 2014

 

  1. “A study of Fibreoptic Broncoscopy in Non Resolving Pneumonia”, Indian Journal of Applied Research, Volume -5, issue 12, Page no. 1 to 3, December 2015, ISSN-2249-555X, IMPACT FACTOR:3.6241
  2. “Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India: an intrim analysis” Europian Respiratory Journal 46 (suppl59), PA2697, DOI 10.1183/13993003.congress-2015.PA2697 Published in October 2015
  1. Treatment outcome of patients having extensively drug‑resistant tuberculosis

in Gujarat, India. International  Journal Mycobacteriology 2017;6:289-95.

 

  1. Post-COVID-19 respiratory management: Expert Panel Report, The Indian Journal of Chest Diseases & Allied Sciences, Vol 62, no. 4, pages- 177-191, Octo-Dec. 2020
  2. Strengthened capacity of India’s bedaquiline Conditional Access Programme for introducing new drugs and regimens, INT J TUBERC LUNG DIS 24(10):1067–1072, October 2020
  3. Bedaquiline, Delamanid, Linezolid, and Clofazimine for Pre extensively drug-resistant Tuberculosis, Clinical Infectious diseases, 76 (3), DOI 10.1093/cid/ciac528, June 2022
  4. “QTc Prolongation with Bedaquiline Treatment for Drug-Resistant Pulmonary Tuberculosis in Programmatic Setting,”( IJTLD-07-22-0406.R2) accepted for publication in The International Journal of Tuberculosis and Lung, 23 October 2022
  5. Evaluation of two short standardized regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomized, non-inferiority trial, Lancet, November 8, 2022 https://doi.org/10.1016/S0140-6736(22)02078-5
  6.  Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomized controlled trial,  The Lancet, Global Health, www.thelancet.com/lancetgh Published online December 21, 2022 https://doi.org/10.1016/S2214-109X(22)00498-3
  7. Indian Guidelines on Nebulization Therapy, Supplementary (69) s1-s191, Indian Journal of Tuberculosis, July 2022.
  8. “Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis” Volume 12 (4), 714, Antibiotics, April 2023, 
  9. Long-Term Intake of Linezolid Elevates Drug Exposure and Reduces Drug Clearance and Elimination in Adults With Drug-Resistant Pulmonary Tuberculosis, Ther Drug Monitoring, Volume 45, Number 6, December 2023
  10. Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis, Therapeutic Drug Monitoring ():10.1097/FTD.0000000000001164, January 1, 2024

Review Articles:

  1. Publication of Article on “Drug Resistance TB” in World Clinics of Pulmonary Medicine & Critical care Medicine (January 2004: Vol 3)
  2. Participants in “Publication of “Standards of TB Care in India” by WHO India 2014
  3. Participants in “Publication of Standardized Treatment Guidelines” in

Gujarat by Government of Gujarat 2014

  1. Participant in development of National Guideline of “Programmatic Management of

Drug Resistant TB” in India by Central TB Division, Government of India 2005-2006

  1. Participant and Pilot study done for “Airborne Infection Control Measures” for

Tuberculosis in India and developed National Guideline by Central TB Division,

Government of India 2010-2012

  1. Article on “Role of  Medical colleges in Revised National Tuberculosis Control   Programme”, page 465-471, Practical Approach to Tuberculosis Management

Jaypee  Publication, 2006 (ISBN 81-8061-767 X)

  1. Publication of Article on PREVENTION OF TB in Text book of Pulmonary and

Critical Care Medicine (Volume-1) Page no. 608-615, Jaypee Brothers Medical 

Publication (P) LTD. 2011 (ISBN -978-93-5025-073-0)

  1. Publication of Article on OCCUPATIONAL LUNG DISEASES in NCCP Text book

of Respiratory Medicine, Page no. 834-844,  Jaypee Brothers Medical  Publication  (P) LTD. 2011 (ISBN -978-93-5025-212-3)

  1. Publication of Article on DIFFICULT BRONCHIAL ASTHMA in NCCP Text book of Respiratory Medicine, Page no. 569-576,  Jaypee Brothers Medical 

Publication (P) LTD. 2011 (ISBN -978-93-5025-212-3)

Dr Bhogilal V Patel

  1. Publication of Article on ”Etiology and clinical profile of pleural effusion in a tertiary care center of India: A descriptive study” International Journal of Pharmaceutical and Clinical Research,15(6) 609-616, 2023 (e-ISSN:0975-1556, p-ISSN:2820-2643)
  2. Publication of Article on” A study of correlation between severity score of HRCT Chest and clinical parameters of adult patients admitted with COVID-19 at medical college, north Gujarat, India,” International Journal of Academic Medicine and Pharmacy “, Volume-5, Issue-1, 2023 ( e-ISSN:2687-5365, Pissn: 2753-6556)

 

Dr Jaysinh N Rathva

            Attended Allergy Workshop at V P Chest Institute, January 2023, New Delhi

Scroll to Top